您当前的位置:
首页 >
文章列表页 >
The related mechanism of radiotherapy in triple-negative breast cancer
更新时间:2025-12-31
    • The related mechanism of radiotherapy in triple-negative breast cancer

    • China Oncology   Vol. 24, Issue 11, Pages: 865-870(2014)
    • DOI:10.3969/j.issn.1007-3969.2014.11.012    

      CLC:
    • Published Online:05 May 2015

      Published:05 May 2014

    移动端阅览

  • 李冰馨, 傅深. The related mechanism of radiotherapy in triple-negative breast cancer[J]. China Oncology, 2014, 24(11): 865-870. DOI: 10.3969/j.issn.1007-3969.2014.11.012.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

2876

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Treatment strategies and prognostic analysis of 87 patients with salivary duct carcinoma: a retrospective cohort study
TIPE regulates glucometabolic reprogramming by modulating LDHA expression in triple-negative breast cancer
Current status and prospects of tertiary lymphoid structure heterogeneity in predicting response to neoadjuvant therapy and characterizing immune microenvironment in triple-negative breast cancer
The progress of treatment for brain metastases of triple-negative breast cancer
Advancements in the research of immunomodulatory effects of radiation therapy: from basic to clinical

Related Author

Ximei ZHANG
Yixuan ZHOU
Yan ZHAO
Xuan ZHOU
Xudong WANG
Yingbin YAN
Peiguo WANG
Wei HU

Related Institution

Department of Maxillofacial Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors
Tianjin Key Laboratory of Oral and Maxillofacial Functional Reconstruction
Department of Oral and Maxillofacial-Head and Neck Surgery, Tianjin Stomatological Hospital Affiliated to Nankai University School of Medicine
Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors
Tianjin Clinical Research Center for Malignant Tumors
0